3-D QSAR studies on new dibenzyltin(IV) anticancer agents by comparative molecular field analysis (CoMFA)

Bioorganic and Medicinal Chemistry Letters

Volumn 12, Issue 1, 2002, Pages 61-64

  Samuel, Purnima M ^a   Vos, Dick De ^b   Raveendra, D ^a   Sarma, J A R P ^a   Roy, Sujit ^c  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b TEVA Pharmachemie   (Netherlands)

^c INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DIBENZYLTIN; ORGANOTIN COMPOUND; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; BREAST CARCINOMA; COLON CARCINOMA; COMPARATIVE MOLECULAR FIELD ANALYSIS; CONTROLLED STUDY; CYTOTOXICITY; MODEL; MOUSE; NONHUMAN; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; BENZYL COMPOUNDS; CELL DEATH; DRUG EVALUATION, PRECLINICAL; HUMANS; LIGANDS; MICE; MODELS, MOLECULAR; ORGANOTIN COMPOUNDS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0037033176     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(01)00684-9     Document Type: Article

References (28)